XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Cash flows from operating activities:    
Net income (loss) including non-controlling interests $ 46,044 $ (4,423,624)
Adjustments to reconcile net income (loss) including non-controlling interests to net cash provided by operating activities:    
Depreciation, depletion and amortization 78,958 236,885
Gain on extinguishment of debt 0 (83,887)
Gain on sale of properties (223,068) (10,179)
Impairment 5 4,825,997
Deferred income taxes 0 (257,315)
Derivative instruments 448,552 (248,135)
Equity-based compensation expenses 6,900 11,697
Deferred financing costs amortization and other 16,289 16,755
Working capital and other changes:    
Change in accounts receivable, net (96,704) 167,871
Change in inventory (2,880) (8,739)
Change in prepaid expenses 3,773 (7,465)
Change in accounts payable, interest payable and accrued liabilities 80,969 (156,668)
Change in other assets and liabilities, net (8,475) (3,298)
Net cash provided by operating activities 350,363 59,895
Cash flows from investing activities:    
Capital expenditures (85,217) (270,283)
Acquisition deposit (74,500) 0
Proceeds from sale of properties 369,819 13,780
Costs related to sale of properties (2,358) 0
Derivative settlements (78,575) 144,069
Derivative modification (82,419) 0
Net cash provided by (used in) investing activities 46,750 (112,434)
Cash flows from financing activities:    
Proceeds from revolving credit facilities 369,500 577,000
Principal payments on revolving credit facilities (866,500) (383,000)
Proceeds from issuance of senior unsecured notes 850,000 0
Repurchase of senior unsecured notes 0 (68,040)
Deferred financing costs (20,332) (102)
Proceeds from issuance of OMP common units, net of offering costs 86,657 0
Common control transaction costs (5,432) 0
Purchases of treasury stock (14,560) (2,626)
Dividends paid (15,039) 0
Distributions to non-controlling interests (12,165) (12,042)
Payments on finance lease liabilities (726) (1,262)
Proceeds from warrants exercised 173 0
Net cash provided by financing activities 371,576 109,928
Increase in cash, cash equivalents and restricted cash 768,689 57,389
Cash, cash equivalents and restricted cash:    
Beginning of period 20,226 20,019
End of period 788,915 77,408
Supplemental non-cash transactions:    
Change in accrued capital expenditures 11,515 (60,655)
Change in asset retirement obligations (1,370) 2,039
Note receivable from divestiture 2,900 0
Contingent consideration from Permian Basin Sale 32,860 0
Dividends payable $ 83,543 $ 0